HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
Top Cited Papers
Open Access
- 30 June 2008
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 14 (6), 641-650
- https://doi.org/10.1016/j.bbmt.2008.03.005
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic diseaseBlood, 2007
- A Comparison of Allografting with Autografting for Newly Diagnosed MyelomaThe New England Journal of Medicine, 2007
- Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in AdultsTransplantation and Cellular Therapy, 2007
- Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological DiseasesClinical Cancer Research, 2004
- Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioningBlood, 2003
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993
- Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphomaHuman Immunology, 1990
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaThe New England Journal of Medicine, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958